Literature DB >> 21910613

The end-of-life family meeting in intensive care part III: A guide for structured discussions.

J Andrew Billings1, Susan D Block.   

Abstract

Mesh：

Year:  2011        PMID： 21910613     DOI： 10.1089/jpm.2011.0038-c

Source DB:  PubMed          Journal:  J Palliat Med        ISSN： 1557-7740            Impact factor:   2.947


× No keyword cloud information.
  6 in total

1.  Adaptive leadership: a novel approach for family decision making.

Authors:  Judith Adams; Donald E Bailey; Ruth A Anderson; Anthony N Galanos
Journal:  J Palliat Med       Date:  2012-06-04       Impact factor: 2.947

2.  The use of family conferences in the pediatric intensive care unit.

Authors:  Kelly Nicole Michelson; Marla L Clayman; Natalie Haber-Barker; Claire Ryan; Karen Rychlik; Linda Emanuel; Joel Frader
Journal:  J Palliat Med       Date:  2013-10-31       Impact factor: 2.947

3.  Ten practical strategies for effective communication with relatives of ICU patients.

Authors:  Stephen Warrillow; K J Farley; Daryl Jones
Journal:  Intensive Care Med       Date:  2015-04-23       Impact factor: 17.440

4.  Hospital-Based Physicians' Intubation Decisions and Associated Mental Models when Managing a Critically and Terminally Ill Older Patient.

Authors:  Shannon Haliko; Julie Downs; Deepika Mohan; Robert Arnold; Amber E Barnato
Journal:  Med Decis Making       Date:  2017-11-22       Impact factor: 2.583

Review 5.  A Systematic Review of Family Meeting Tools in Palliative and Intensive Care Settings.

Authors:  Adam E Singer; Tayla Ash; Claudia Ochotorena; Karl A Lorenz; Kelly Chong; Scott T Shreve; Sangeeta C Ahluwalia
Journal:  Am J Hosp Palliat Care       Date:  2015-07-26       Impact factor: 2.500

6.  COMmunication with Families regarding ORgan and Tissue donation after death in intensive care (COMFORT): protocol for an intervention study.

Authors:  Julie E Potter; Robert G Herkes; Lin Perry; Rosalind M Elliott; Anders Aneman; Jorge L Brieva; Elena Cavazzoni; Andrew T H Cheng; Michael J O'Leary; Ian M Seppelt; Val Gebski
Journal:  BMC Health Serv Res       Date:  2017-01-17       Impact factor: 2.655
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.